Creative Medical Technology - Female Dysfunction

Not only is Stock Symbol CELZ have a ground breaking procedure for male sexual dysfunction, but they are currently working on a procedure for the female sexual dysfunction (FSD) called AmnioStem.

AmnioStem:

• Damage to blood vessels and smooth muscle tissue due to disease and lifestyle play a role in female sexual dysfunction (FSD)

• Animal studies validate tissue damage affects FSD

• Research is just beginning to focus on physical factors beyond emotional and hormonal

• CMTH has files US patent application number #62319753 covering the treatment of female sexual dysfunction using stem cell and progenitor cell populations

• Regenerates the smooth muscle and vasculature associated with clitoral and vaginal function

• Pre-clinical research ongoing, clinical trials scheduled for 2018